Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine.

Zhong Z, Portela Catani JP, Mc Cafferty S, Couck L, Van Den Broeck W, Gorlé N, Vandenbroucke RE, Devriendt B, Ulbert S, Cnops L, Michels J, Ariën KK, Sanders NN.

Vaccines (Basel). 2019 Aug 23;7(3). pii: E96. doi: 10.3390/vaccines7030096.

2.

West Nile virus vaccines - current situation and future directions.

Ulbert S.

Hum Vaccin Immunother. 2019 Jul 10:1-6. doi: 10.1080/21645515.2019.1621149. [Epub ahead of print]

PMID:
31116691
3.

Specific detection and differentiation of tick-borne encephalitis and West Nile virus induced IgG antibodies in humans and horses.

Rockstroh A, Moges B, Berneck BS, Sattler T, Revilla-Fernández S, Schmoll F, Pacenti M, Sinigaglia A, Barzon L, Schmidt-Chanasit J, Nowotny N, Ulbert S.

Transbound Emerg Dis. 2019 Jul;66(4):1701-1708. doi: 10.1111/tbed.13205. Epub 2019 Apr 29.

PMID:
30985075
4.

Eimeria tenella oocysts attenuated by low energy electron irradiation (LEEI) induce protection against challenge infection in chickens.

Thabet A, Schmäschke R, Fertey J, Bangoura B, Schönfelder J, Lendner M, Ulbert S, Daugschies A.

Vet Parasitol. 2019 Feb;266:18-26. doi: 10.1016/j.vetpar.2019.01.001. Epub 2019 Jan 6.

PMID:
30736944
5.

Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil.

Bozza FA, Moreira-Soto A, Rockstroh A, Fischer C, Nascimento AD, Calheiros AS, Drosten C, Bozza PT, Souza TML, Ulbert S, Drexler JF.

Emerg Infect Dis. 2019 Feb;25(2):311-315. doi: 10.3201/eid2502.180166.

6.

Dengue Virus IgM Serotyping by ELISA with Recombinant Mutant Envelope Proteins.

Rockstroh A, Barzon L, Kumbukgolla W, Su HX, Lizarazo E, Vincenti-Gonzalez MF, Tami A, Ornelas AMM, Aguiar RS, Cadar D, Schmidt-Chanasit J, Ulbert S.

Emerg Infect Dis. 2019 Jan;25(1):1111-1115. doi: 10.3201/eid2501.180605. Epub 2019 Jan 17.

7.

Exhaustive TORCH Pathogen Diagnostics Corroborate Zika Virus Etiology of Congenital Malformations in Northeastern Brazil.

Moreira-Soto A, Cabral R, Pedroso C, Eschbach-Bludau M, Rockstroh A, Vargas LA, Postigo-Hidalgo I, Luz E, Sampaio GS, Drosten C, Netto EM, Jaenisch T, Ulbert S, Sarno M, Brites C, Drexler JF.

mSphere. 2018 Aug 8;3(4). pii: e00278-18. doi: 10.1128/mSphere.00278-18.

8.

Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice.

Bayer L, Fertey J, Ulbert S, Grunwald T.

Vaccine. 2018 Mar 14;36(12):1561-1569. doi: 10.1016/j.vaccine.2018.02.014. Epub 2018 Feb 10.

PMID:
29439869
9.

Evidence for Congenital Zika Virus Infection From Neutralizing Antibody Titers in Maternal Sera, Northeastern Brazil.

Moreira-Soto A, Sarno M, Pedroso C, Netto EM, Rockstroh A, Luz E, Feldmann M, Fischer C, Bastos FA, Kümmerer BM, de Lamballerie X, Drosten C, Ulbert S, Brites C, Drexler JF.

J Infect Dis. 2017 Dec 19;216(12):1501-1504. doi: 10.1093/infdis/jix539.

10.

High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks.

Netto EM, Moreira-Soto A, Pedroso C, Höser C, Funk S, Kucharski AJ, Rockstroh A, Kümmerer BM, Sampaio GS, Luz E, Vaz SN, Dias JP, Bastos FA, Cabral R, Kistemann T, Ulbert S, de Lamballerie X, Jaenisch T, Brady OJ, Drosten C, Sarno M, Brites C, Drexler JF.

MBio. 2017 Nov 14;8(6). pii: e01390-17. doi: 10.1128/mBio.01390-17.

11.

Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.

Rockstroh A, Moges B, Barzon L, Sinigaglia A, Palù G, Kumbukgolla W, Schmidt-Chanasit J, Sarno M, Brites C, Moreira-Soto A, Drexler JF, Ferreira OC, Ulbert S.

Emerg Microbes Infect. 2017 Nov 8;6(11):e99. doi: 10.1038/emi.2017.87.

12.

Pathogens Inactivated by Low-Energy-Electron Irradiation Maintain Antigenic Properties and Induce Protective Immune Responses.

Fertey J, Bayer L, Grunwald T, Pohl A, Beckmann J, Gotzmann G, Casado JP, Schönfelder J, Rögner FH, Wetzel C, Thoma M, Bailer SM, Hiller E, Rupp S, Ulbert S.

Viruses. 2016 Nov 23;8(11). pii: E319.

13.

A method to identify protein antigens of Dermanyssus gallinae for the protection of birds from poultry mites.

Makert GR, Vorbrüggen S, Krautwald-Junghanns ME, Voss M, Sohn K, Buschmann T, Ulbert S.

Parasitol Res. 2016 Jul;115(7):2705-13. doi: 10.1007/s00436-016-5017-2. Epub 2016 Mar 30.

PMID:
27026505
14.

Recombinant Envelope-Proteins with Mutations in the Conserved Fusion Loop Allow Specific Serological Diagnosis of Dengue-Infections.

Rockstroh A, Barzon L, Pacenti M, Palù G, Niedrig M, Ulbert S.

PLoS Negl Trop Dis. 2015 Nov 13;9(11):e0004218. doi: 10.1371/journal.pntd.0004218. eCollection 2015 Nov.

15.

DNA vaccines encoding the envelope protein of West Nile virus lineages 1 or 2 administered intramuscularly, via electroporation and with recombinant virus protein induce partial protection in large falcons (Falco spp.).

Fischer D, Angenvoort J, Ziegler U, Fast C, Maier K, Chabierski S, Eiden M, Ulbert S, Groschup MH, Lierz M.

Vet Res. 2015 Aug 17;46:87. doi: 10.1186/s13567-015-0220-1.

16.

Phylogenetic characterization of Central/Southern European lineage 2 West Nile virus: analysis of human outbreaks in Italy and Greece, 2013-2014.

Barzon L, Papa A, Lavezzo E, Franchin E, Pacenti M, Sinigaglia A, Masi G, Trevisan M, Squarzon L, Toppo S, Papadopoulou E, Nowotny N, Ulbert S, Piralla A, Rovida F, Baldanti F, Percivalle E, Palù G.

Clin Microbiol Infect. 2015 Dec;21(12):1122.e1-10. doi: 10.1016/j.cmi.2015.07.018. Epub 2015 Jul 31.

17.

The challenge of West Nile virus in Europe: knowledge gaps and research priorities.

Rizzoli A, Jimenez-Clavero MA, Barzon L, Cordioli P, Figuerola J, Koraka P, Martina B, Moreno A, Nowotny N, Pardigon N, Sanders N, Ulbert S, Tenorio A.

Euro Surveill. 2015 May 21;20(20). pii: 21135. Review.

18.

Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.

Grunwald T, Ulbert S.

Clin Exp Vaccine Res. 2015 Jan;4(1):1-10. doi: 10.7774/cevr.2015.4.1.1. Epub 2015 Jan 30. Review.

19.

Latest developments and challenges in the diagnosis of human West Nile virus infection.

Barzon L, Pacenti M, Ulbert S, Palù G.

Expert Rev Anti Infect Ther. 2015 Mar;13(3):327-42. doi: 10.1586/14787210.2015.1007044. Epub 2015 Feb 2. Review.

PMID:
25641365
20.

T cell epitope mapping of the e-protein of West Nile virus in BALB/c mice.

De Filette M, Chabierski S, Andries O, Ulbert S, Sanders NN.

PLoS One. 2014 Dec 15;9(12):e115343. doi: 10.1371/journal.pone.0115343. eCollection 2014.

21.

Technologies for the development of West Nile virus vaccines.

Ulbert S, Magnusson SE.

Future Microbiol. 2014;9(10):1221-32. doi: 10.2217/fmb.14.67. Review.

22.

Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.

Verstrepen BE, Oostermeijer H, Fagrouch Z, van Heteren M, Niphuis H, Haaksma T, Kondova I, Bogers WM, de Filette M, Sanders N, Stertman L, Magnusson S, Lőrincz O, Lisziewicz J, Barzon L, Palù G, Diamond MS, Chabierski S, Ulbert S, Verschoor EJ.

PLoS One. 2014 Nov 13;9(11):e112568. doi: 10.1371/journal.pone.0112568. eCollection 2014.

23.

AUF1 p45 promotes West Nile virus replication by an RNA chaperone activity that supports cyclization of the viral genome.

Friedrich S, Schmidt T, Geissler R, Lilie H, Chabierski S, Ulbert S, Liebert UG, Golbik RP, Behrens SE.

J Virol. 2014 Oct;88(19):11586-99. doi: 10.1128/JVI.01283-14. Epub 2014 Jul 30.

24.

Isolation of West Nile virus from urine samples of patients with acute infection.

Barzon L, Pacenti M, Franchin E, Squarzon L, Sinigaglia A, Ulbert S, Cusinato R, Palù G.

J Clin Microbiol. 2014 Sep;52(9):3411-3. doi: 10.1128/JCM.01328-14. Epub 2014 Jun 20.

25.

Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop.

Chabierski S, Barzon L, Papa A, Niedrig M, Bramson JL, Richner JM, Palù G, Diamond MS, Ulbert S.

BMC Infect Dis. 2014 May 9;14:246. doi: 10.1186/1471-2334-14-246.

26.

Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virus.

Verstrepen BE, Fagrouch Z, van Heteren M, Buitendijk H, Haaksma T, Beenhakker N, Palù G, Richner JM, Diamond MS, Bogers WM, Barzon L, Chabierski S, Ulbert S, Kondova I, Verschoor EJ.

PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2797. doi: 10.1371/journal.pntd.0002797. eCollection 2014 Apr.

27.

Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.

De Filette M, Soehle S, Ulbert S, Richner J, Diamond MS, Sinigaglia A, Barzon L, Roels S, Lisziewicz J, Lorincz O, Sanders NN.

PLoS One. 2014 Feb 4;9(2):e87837. doi: 10.1371/journal.pone.0087837. eCollection 2014. Erratum in: PLoS One. 2014;9(2):e91631.

28.

Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.

Magnusson SE, Karlsson KH, Reimer JM, Corbach-Söhle S, Patel S, Richner JM, Nowotny N, Barzon L, Bengtsson KL, Ulbert S, Diamond MS, Stertman L.

Vaccine. 2014 Feb 7;32(7):800-8. doi: 10.1016/j.vaccine.2013.12.030. Epub 2013 Dec 28.

PMID:
24380682
29.

Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe.

Chabierski S, Makert GR, Kerzhner A, Barzon L, Fiebig P, Liebert UG, Papa A, Richner JM, Niedrig M, Diamond MS, Palù G, Ulbert S.

PLoS One. 2013 Jun 12;8(6):e66507. doi: 10.1371/journal.pone.0066507. Print 2013.

30.

Recent progress in West Nile virus diagnosis and vaccination.

De Filette M, Ulbert S, Diamond M, Sanders NN.

Vet Res. 2012 Mar 1;43:16. doi: 10.1186/1297-9716-43-16. Review.

31.

A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.

Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Bürki K, Liebert UG, Ulbert S.

Vaccine. 2011 Aug 26;29(37):6352-7. doi: 10.1016/j.vaccine.2011.04.116. Epub 2011 May 17.

PMID:
21596075
32.

West Nile virus: the complex biology of an emerging pathogen.

Ulbert S.

Intervirology. 2011;54(4):171-84. doi: 10.1159/000328320. Epub 2011 May 16. Review.

33.

Synergistic effects between natural histone mixtures and polyethylenimine in non-viral gene delivery in vitro.

Schneeweiss A, Buyens K, Giese M, Sanders N, Ulbert S.

Int J Pharm. 2010 Nov 15;400(1-2):86-95. doi: 10.1016/j.ijpharm.2010.08.036. Epub 2010 Sep 9.

PMID:
20816738
34.

RNA interference protects horse cells in vitro from infection with Equine Arteritis Virus.

Heinrich A, Riethmüller D, Gloger M, Schusser GF, Giese M, Ulbert S.

Antiviral Res. 2009 Mar;81(3):209-16. doi: 10.1016/j.antiviral.2008.10.004. Epub 2008 Nov 11.

PMID:
19007819
35.

The inner nuclear membrane protein Lem2 is critical for normal nuclear envelope morphology.

Ulbert S, Antonin W, Platani M, Mattaj IW.

FEBS Lett. 2006 Nov 27;580(27):6435-41. Epub 2006 Nov 3.

36.

Direct membrane protein-DNA interactions required early in nuclear envelope assembly.

Ulbert S, Platani M, Boue S, Mattaj IW.

J Cell Biol. 2006 May 22;173(4):469-76.

37.

Base J, found in nuclear DNA of Trypanosoma brucei, is not a target for DNA glycosylases.

Ulbert S, Eide L, Seeberg E, Borst P.

DNA Repair (Amst). 2004 Feb 3;3(2):145-54.

PMID:
14706348
38.

Expression of the human DNA glycosylase hSMUG1 in Trypanosoma brucei causes DNA damage and interferes with J biosynthesis.

Ulbert S, Cross M, Boorstein RJ, Teebor GW, Borst P.

Nucleic Acids Res. 2002 Sep 15;30(18):3919-26.

39.

Expression site activation in Trypanosoma brucei with three marked variant surface glycoprotein gene expression sites.

Ulbert S, Chaves I, Borst P.

Mol Biochem Parasitol. 2002 Apr 9;120(2):225-35.

PMID:
11897128
40.

Control of VSG gene expression sites.

Borst P, Ulbert S.

Mol Biochem Parasitol. 2001 Apr 25;114(1):17-27. Review.

PMID:
11356510
41.

Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection.

Luty AJ, Ulbert S, Lell B, Lehman L, Schmidt-Ott R, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Dubois B, Deloron P, Kremsner PG.

Am J Trop Med Hyg. 2000 May;62(5):566-72.

PMID:
11289665
42.

Characterization of a candidate Trypanosoma brucei U1 small nuclear RNA gene.

Djikeng A, Ferreira L, D'Angelo M, Dolezal P, Lamb T, Murta S, Triggs V, Ulbert S, Villarino A, Renzi S, Ullu E, Tschudi C.

Mol Biochem Parasitol. 2001 Mar;113(1):109-15.

PMID:
11254959
43.

Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria.

Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Ulbert S, Migot-Nabias F, Dubois B, Deloron P, Kremsner PG.

Eur Cytokine Netw. 1998 Dec;9(4):639-46.

44.

Fermentation production of L-homoserine by Corynebacterium sp. and its possible use in the preparation of threonine and lysine.

Plachý J, Ulbert S, Pelechová J, Krumphanzl V.

Folia Microbiol (Praha). 1985;30(6):485-92.

PMID:
3936757

Supplemental Content

Loading ...
Support Center